Chaetoglobosin F, a small molecule compound, possesses immunomodulatory properties on bone marrow-derived dendritic cells via TLR9 signaling pathway

Immunobiology

Volumn 218, Issue 3, 2013, Pages 292-302

  Hua, Chunyan ^a   Yang, Yonghong ^a   Sun, Lin ^a   Dou, Huan ^a   Tan, Renxiang ^a   Hou, Yayi ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chaetoglobosin F; DCs; MAPKs; NF B; STAT1; TLR9

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CHAETOGLOBOSIN F; CHOLECYSTOKININ OCTAPEPTIDE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL FUNCTION; CELL MATURATION; CELL NUCLEUS; CELL TRANSPORT; CELL VIABILITY; CHAETOMIUM; CHEMOKINESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG STRUCTURE; ENDOCYTOSIS; ENZYME ACTIVATION; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; T LYMPHOCYTE;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHAETOMIUM; CHEMOKINE CXCL10; DENDRITIC CELLS; GENE EXPRESSION REGULATION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INDOLE ALKALOIDS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 84873144724     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.015     Document Type: Article

References (53)

1. Abou Fakher F.H., Rachinel N., Klimczak M., Louis J., Doyen N. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J. Immunol. 2009, 182:1386-1396.
2. 2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells. Cell. Signal. 2006, 18:1801-1812.
3. An H., Xu H., Yu Y., Zhang M., Qi R., Yan X., Liu S., Wang W., Guo Z., Qin Z., Cao X. Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunol. Lett. 2002, 81:165-169.
4. Bansal K., Elluru S.R., Narayana Y., Chaturvedi R., Patil S.A., Kaveri S.V., Bayry J., Balaji K.N. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J. Immunol. 2010, 184:3495-3504.
5. Bhan U., Newstead M.J., Zeng X., Ballinger M.N., Standiford L.R., Standiford T.J. Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent. Am. J. Pathol. 2011, 179:2779-2787.
6. Blanco P., Palucka A.K., Pascual V., Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008, 19:41-52.
7. Boudreau J.E., Bonehill A., Thielemans K., Wan Y. Engineering dendritic cells to enhance cancer immunotherapy. Mol. Ther. 2011, 19:841-853.
8. Carregaro V., Sa-Nunes A., Cunha T.M., Grespan R., Oliveira C.J., Lima-Junior D.S., Costa D.L., Verri W.A., Milanezi C.M., Pham V.M., Brand D.D., Valenzuela J.G., Silva J.S., Ribeiro J.M., Cunha F.Q. Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions. J. Immunol. 2011, 187:4347-4359.
9. Chen G., Gulbranson D.R., Yu P., Hou Z., Thomson J.A. Thermal stability of FGF protein is a determinant factor in regulating self-renewal, differentiation and reprogramming in human pluripotent stem cells. Stem Cells 2011, 30:623-630.
10. Dalod M., Salazar-Mather T.P., Malmgaard L., Lewis C., Asselin-Paturel C., Briere F., Trinchieri G., Biron C.A. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 2002, 195:517-528.
11. Delamarre L., Mellman I. Harnessing dendritic cells for immunotherapy. Semin. Immunol. 2011, 23:2-11.
12. Ding G., Song Y.C., Chen J.R., Xu C., Ge H.M., Wang X.T., Tan R.X. Chaetoglobosin U, a cytochalasan alkaloid from endophytic Chaetomium globosum IFB-E019. J. Nat. Prod. 2006, 69:302-304.
13. Dou H., Song Y., Liu X., Gong W., Li E., Tan R., Hou Y. Chaetoglobosin Fex from the marine-derived endophytic fungus inhibits induction of inflammatory mediators via Toll-like receptor 4 signaling in macrophages. Biol. Pharm. Bull. 2011, 34:1864-1873.
14. Dunne A., Marshall N.A., Mills K.H. TLR based therapeutics. Curr. Opin. Pharmacol. 2011, 11:404-411.
15. Ezzelarab M., Thomson A.W. Tolerogenic dendritic cells and their role in transplantation. Semin. Immunol. 2011, 23:252-263.
16. Ganesan A. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol. 2008, 12:306-317.
17. Gerl V., Lischka A., Panne D., Grossmann P., Berthold R., Hoyer B.F., Biesen R., Bruns A., Alexander T., Jacobi A., Dorner T., Burmester G.R., Radbruch A., Hiepe F. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function. Ann. Rheum. Dis. 2010, 69:1370-1377.
18. Hennessy E.J., Parker A.E., O'Neill L.A. Targeting Toll-like receptors: emerging therapeutics?. Nat. Rev. Drug Discov. 2010, 9:293-307.
19. Hoshino K., Kaisho T. Nucleic acid sensing Toll-like receptors in dendritic cells. Curr. Opin. Immunol. 2008, 20:408-413.
20. Jackson S.H., Yu C.R., Mahdi R.M., Ebong S., Egwuagu C.E. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J. Immunol. 2004, 172:2307-2315.
21. Kagatani S., Sasaki Y., Hirota M., Mizuashi M., Suzuki M., Ohtani T., Itagaki H., Aiba S. Oxidation of cell surface thiol groups by contact sensitizers triggers the maturation of dendritic cells. J. Invest. Dermatol. 2010, 130:175-183.
22. Kaisho T., Tanaka T. Turning NF-kappaB and IRFs on and off in DC. Trends Immunol. 2008, 29:329-336.
23. Krummen M., Balkow S., Shen L., Heinz S., Loquai C., Probst H.C., Grabbe S. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. J. Leukoc. Biol. 2010, 88:189-199.
24. Kumagai Y., Takeuchi O., Akira S. TLR9 as a key receptor for the recognition of DNA. Adv. Drug Deliv. Rev. 2008, 60:795-804.
25. Lambrecht B.N. Lung dendritic cells: targets for therapy in allergic disease. Curr. Mol. Med. 2008, 8:393-400.
26. Lee H.S., Kim H.R., Lee E.H., Jang M.H., Kim S.B., Park J.W., Seoh J.Y., Jung Y.J. Characterization of CCR9 expression and thymus-expressed chemokine responsiveness of the murine thymus, spleen and mesenteric lymph node. Immunobiology 2012, 217:402-411.
27. Lutz M.B., Assmann C.U., Girolomoni G., Ricciardi-Castagnoli P. Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line. Eur. J. Immunol. 1996, 26:586-594.
28. Manicassamy S., Pulendran B. Dendritic cell control of tolerogenic responses. Immunol. Rev. 2011, 241:206-227.
29. Moser M. Dendritic cells in immunity and tolerance-do they display opposite functions?. Immunity 2003, 19:5-8.
30. Mouchess M.L., Arpaia N., Souza G., Barbalat R., Ewald S.E., Lau L., Barton G.M. Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation. Immunity 2011, 35:721-732.
31. Oeckinghaus A., Hayden M.S., Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat. Immunol. 2011, 12:695-708.
32. Otsuka A., Kubo M., Honda T., Egawa G., Nakajima S., Tanizaki H., Kim B., Matsuoka S., Watanabe T., Nakae S., Miyachi Y., Kabashima K. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One. 2011, 6:e25538.
33. Papadimitraki E.D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., Raptopoulou A., Kritikos H.D., Mamalaki C., Sidiropoulos P., Boumpas D.T. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006, 54:3601-3611.
34. Pedersen A.W., Claesson M.H., Zocca M.B. Dendritic cells modified by vitamin D: future immunotherapy for autoimmune diseases. Vitam. Horm. 2011, 86:63-82.
35. Pufnock J.S., Cigal M., Rolczynski L.S., Andersen-Nissen E., Wolfl M., McElrath M.J., Greenberg P.D. Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28. Blood 2011, 117:6542-6551.
36. Randolph G.J., Sanchez-Schmitz G., Angeli V. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin. Immunopathol. 2005, 26:273-287.
37. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6:476-483.
38. Rescigno M. Dendritic cells in tolerance induction for the treatment of autoimmune diseases. Eur. J. Immunol. 2010, 40:2119-2123.
39. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188:2175-2180.
40. Robak E., Robak T. Novel and emerging drugs for systemic lupus erythematosus: mechanism of action and therapeutic activity. Curr. Med. Chem. 2012, 19:438-453.
41. Rosas L.E., Barbi J., Lu B., Fujiwara Y., Gerard C., Sanders V.M., Satoskar A.R. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection. Eur. J. Immunol. 2005, 35:515-523.
42. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995, 182:389-400.
43. Schroder K., Spille M., Pilz A., Lattin J., Bode K.A., Irvine K.M., Burrows A.D., Ravasi T., Weighardt H., Stacey K.J., Decker T., Hume D.A., Dalpke A.H., Sweet M.J. Differential effects of CpG DNA on IFN-beta induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages. J. Immunol. 2007, 179:3495-3503.
44. Schumann J., Hertweck C. Molecular basis of cytochalasan biosynthesis in fungi: gene cluster analysis and evidence for the involvement of a PKS-NRPS hybrid synthase by RNA silencing. J. Am. Chem. Soc. 2007, 129:9564-9565.
45. Stoop J.N., Robinson J.H., Hilkens C.M. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?. Ann. Rheum. Dis. 2011, 70:1526-1533.
46. Tanos T., Marinissen M.J., Leskow F.C., Hochbaum D., Martinetto H., Gutkind J.S., Coso O.A. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J. Biol. Chem. 2005, 280:18842-18852.
47. Trieu A., Roberts T.L., Dunn J.A., Sweet M.J., Stacey K.J. DNA motifs suppressing TLR9 responses. Crit. Rev. Immunol. 2006, 26:527-544.
48. van der Aar A.M., Sibiryak D.S., Bakdash G., van Capel T.M., van der Kleij H.P., Opstelten D.J., Teunissen M.B., Kapsenberg M.L., de Jong E.C. Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J. Allergy Clin. Immunol. 2011, 127:1532-1540. e1537.
49. van Vliet S.J., den Dunnen J., Gringhuis S.I., Geijtenbeek T.B., van Kooyk Y. Innate signaling and regulation of dendritic cell immunity. Curr. Opin. Immunol. 2007, 19:435-440.
50. Wu O., Chen G.P., Chen H., Li X.P., Xu J.H., Zhao S.S., Sheng J., Feng J.B., Cai J., Fang X.H., Zhang W.H., Li L.H., Zhang N., Li J., Li J.J., Pan F.M., Wang C.Z., Ye D.Q. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. Immunobiology 2009, 214:392-402.
51. Xie H., Hua C., Sun L., Zhao X., Fan H., Dou H., Hou Y. 17beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum. 2011, 63:2425-2435.
52. Zhang Y., Tian R., Liu S., Chen X., Liu X., Che Y. Alachalasins A-G, new cytochalasins from the fungus Stachybotrys Podospora vesticola [corrected]. Bioorg. Med. Chem. 2008, 16:2627-2634.
53. Zhao J., Legge K., Perlman S. Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J. Clin. Invest. 2011, 121:4921-4930.